from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0399c/lpqK

LFCtreatmentdescriptionclass of inhibitor

-0.395

Amikacinug/mL Amikacintranslation

-0.422

Cap5-10ug/mL Capreomycintranslation

-0.943

Rox10-50 ug/mL Roxithromycintranslation

0.786

SM2-5 ug/mL Streptomycintranslation

-1.269

Tet5-10 ug/mL Tetracyclinetranslation

-0.912

Rif0.2-5ug/mL Rifampicintranscription

0.097

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.034

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.295

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.428

CPZ10-50 ug/mL Chlorpromazinerespiration

1.931

Clofazimine10-13 ug/mL Clofaziminerespiration

0.784

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.930

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.260

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.301

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.161

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.271

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.897

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.019

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.507

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.824

KCN5-20 ug/mL Potassium cyaniderespiration

0.704

NaN30.2-2 mM Sodium aziderespiration

0.326

Nigericin50 uM Nigericinrespiration

0.512

TRC10-150 ug/mL Triclosanrespiration

0.725

TRZ10-25 ug/mL Thioridazinerespiration

3.265

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.586

menadione6-10 ug/mL Menadionerespiration

0.120

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.587

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.797

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.234

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.365

NRP_1Non-replicating persistence stage 1dosRassociated

-0.017

Amp0.2mg/mL AmpicillincellWall

-0.307

Cephalexin20-100 ug/mL CephalexincellWall

0.185

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.574

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.452

EMB10-20 ug/mL EthambutolcellWall

-0.228

Eta12-40 ug/mL EthionamidecellWall

-0.461

INH0.2-0.4 ug/mL IsoniazidcellWall

0.060

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.290

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.249

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.206

BZA0.12 mg/mL BenzamidearomaticAmides

-0.387

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.402

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.395

H2O24 mM hydrogen peroxideDNAdamaging

0.252

Levo10 ug/mL LevofloxacinDNAdamaging

-0.836

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.832

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.236

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.797

UVUV-irradiationDNAdamaging

0.093

ARP41-4 ug/mL Antitubercular compound ARP4?

0.019

Antimycin12.5-50 ug/mL Antimycin A?

-0.191

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.228

PA_110-50 ug/mL Antitubercular compound PA-1?

0.453

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.072

PA8240.2-2 ug/mL PA-824?

0.274

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.744

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.809

Verapamil50 uM Verapamil?

-0.265

mercaptoethanol2 mM 2-Mercaptoethanol?

0.446

methoxatin10-20 ug/mL Methoxatin?